InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,898.31
(
0.17%
)
Post# of 251788
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: DewDiligence post# 193903

Wednesday, 07/29/2015 3:27:35 PM

Wednesday, July 29, 2015 3:27:35 PM

Post# of 251788
yes+ Q report+Conference Call,they will focus on the further development of AQX-1125 "in bladder pain syndrome/interstitial cystitis"

Good update might send this over $4 quickly,imo

AQX-1125 is the lead product candidate and has generated positive clinical data from three completed clinical trials, including two proof-of-concept trials.

JOHNSON & JOHNSON, PFIZER INC,and Baker Brothers holding most of float here. Cash/Share=$3.2 PPS

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up